Bartlett JM - Search Results

1

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods.

Bartlett JM, Starczynski J, Atkey N, Kay E, O'Grady A, Gandy M, Ibrahim M, Jasani B, Ellis IO, Pinder SE, Walker RA. Bartlett JM, et al. J Clin Pathol. 2011 Aug;64(8):649-53. doi: 10.1136/jcp.2011.089847. Epub 2011 Jun 20. J Clin Pathol. 2011. PMID: 21690244

2

Recommendations for HER2 testing in the UK.

Ellis IO, Dowsett M, Bartlett J, Walker R, Cooke T, Gullick W, Gusterson B, Mallon E, Lee PB. Ellis IO, et al. J Clin Pathol. 2000 Dec;53(12):890-2. doi: 10.1136/jcp.53.12.890. J Clin Pathol. 2000. PMID: 11265171 Free PMC article.

3

Evaluating HER2 amplification and overexpression in breast cancer.

Bartlett JM, Going JJ, Mallon EA, Watters AD, Reeves JR, Stanton P, Richmond J, Donald B, Ferrier R, Cooke TG. Bartlett JM, et al. J Pathol. 2001 Nov;195(4):422-8. doi: 10.1002/path.971. J Pathol. 2001. PMID: 11745673

4

The clinical evaluation of HER-2 status: which test to use?

Bartlett J, Mallon E, Cooke T. Bartlett J, et al. J Pathol. 2003 Apr;199(4):411-7. doi: 10.1002/path.1354. J Pathol. 2003. PMID: 12635130 Review.

5

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE. Dowsett M, et al. J Pathol. 2003 Apr;199(4):418-23. doi: 10.1002/path.1313. J Pathol. 2003. PMID: 12635131

6

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.

Witton CJ, Reeves JR, Going JJ, Cooke TG, Bartlett JM. Witton CJ, et al. Among authors: bartlett jm. J Pathol. 2003 Jul;200(3):290-7. doi: 10.1002/path.1370. J Pathol. 2003. PMID: 12845624

7

HER2 and COX2 expression in human prostate cancer.

Edwards J, Mukherjee R, Munro AF, Wells AC, Almushatat A, Bartlett JM. Edwards J, et al. Among authors: bartlett jm. Eur J Cancer. 2004 Jan;40(1):50-5. doi: 10.1016/j.ejca.2003.08.010. Eur J Cancer. 2004. PMID: 14687789

8

Best Practice No 176: Updated recommendations for HER2 testing in the UK.

Ellis IO, Bartlett J, Dowsett M, Humphreys S, Jasani B, Miller K, Pinder SE, Rhodes A, Walker R. Ellis IO, et al. J Clin Pathol. 2004 Mar;57(3):233-7. doi: 10.1136/jcp.2003.007724. J Clin Pathol. 2004. PMID: 14990588 Free PMC article.

9

Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer.

Bartlett JM, Brawley D, Grigor K, Munro AF, Dunne B, Edwards J. Bartlett JM, et al. J Pathol. 2005 Mar;205(4):522-9. doi: 10.1002/path.1735. J Pathol. 2005. PMID: 15685688

10

AKT activation predicts outcome in breast cancer patients treated with tamoxifen.

Kirkegaard T, Witton CJ, McGlynn LM, Tovey SM, Dunne B, Lyon A, Bartlett JM. Kirkegaard T, et al. Among authors: bartlett jm. J Pathol. 2005 Oct;207(2):139-46. doi: 10.1002/path.1829. J Pathol. 2005. PMID: 16088978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters